Xue Jiang

Construction of a Tumor Immune Microenvironment-Related Prognostic Model in BRAF-Mutated Papillary Thyroid Cancer

Bo Zhang, Bo Zhang, Qianling Liu, 2022, Frontiers in Endocrinology.

Recent advances in combination therapy with oncolytic virus and immune checkpoint inhibitor for cancer treatment

Xue Jiang, 2020 .

Germline genomes have a dominant-heritable contribution to cancer immune evasion and immunotherapy response

Xue Jiang, Mohammad Asad, Lin Li, 2020, Quantitative Biology.

Pharmacological Activation of Estrogen Receptor Beta Overcomes Tumor Resistance to Immune Checkpoint Blockade Therapy

Shuang Huang, J. Gustafsson, Hongbo Hu, 2020, iScience.